Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

FDA Expands Mylotarg Approval to Include Children With Newly-Diagnosed CD33-Positive AML

June 16th 2020, 8:37pm

Article

The Food and Drug Administration (FDA) extended the indication of Mylotarg (gemtuzumab ozogamicin) to include the treatment of children aged one month or older with newly diagnosed CD33-positive acute myeloid leukemia (AML).

COVID-19 Tips for Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia

April 7th 2020, 7:00pm

Article

The COVID-19 pandemic has created a unique challenge for patients with myelodysplastic syndromes and acute myeloid leukemia, creating many questions that experts tried to answer in a recent webinar from The Aplastic Anemia and MDS International Foundation.

Experts Share Recommendations on Managing Cancer During COVID-19 Pandemic

March 23rd 2020, 7:00pm

Article

The COVID-19 pandemic will continue to alter how patients with cancer receive their treatment, and experts within the United States who saw the virus strike early are offering their advice to other hospitals just starting to feel the effects.

Immunotherapy Combination Offers Hope to Patients with Relapsed/Refractory AML

March 20th 2020, 10:00pm

Article

Patients with acute myeloid leukemia whose disease has relapsed or become resistant to treatment saw a benefit with a combination of Opdivo and Vidaza.

Immunotherapy After Transplant Improves Outcomes in Acute Myeloid Leukemia

March 18th 2020, 5:00pm

Article

Patients with acute myeloid leukemia often have to undergo transplant during treatment but are susceptible to other side effects, but new research indicates that the use of immunotherapy after these treatments can improve patient outcomes.

CURE New Issue Alert: 2020 Hematology Special Edition-1

March 12th 2020, 10:00pm

Video

Here are the latest highlights from the first CURE Hematology Special Edition issue for 2020.

Remission Drives Ambition: Experts Look to New Methods in AML Treatment

March 9th 2020, 5:00pm

Article

Targeted therapies have changed the landscape of cancer care, and now, hope for remission is a possibility for certain patients with acute myeloid leukemia with new approved therapies.

Extending the Options for Patients with AML by Making It Personal

March 3rd 2020, 9:00pm

Article

A wave of new targeted therapies expands the options in acute myeloid leukemia.

Novel Combination May Address Unmet Need in Relapsed or Refractory Acute Myeloid Leukemia

March 2nd 2020, 12:00am

Article

Treatment options for patients with acute myeloid leukemia are limited, especially for older patients, but a new trial looking at novel therapy combinations could change the treatment landscape.

Mutations in Donor Stem Cells Could Harm the Health of Patients with Cancer, Study Finds

January 18th 2020, 3:00am

Article

Research findings show that rare mutations from donor stem cells can be passed onto patients who receive them, potentially causing health concerns.